E2F8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.791400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.700600E-01
Normal-vs-Stage2
2.077400E-01
Normal-vs-Stage3
4.708600E-01
Normal-vs-Stage4
4.428200E-01
Stage1-vs-Stage2
8.832600E-01
Stage1-vs-Stage3
9.581400E-01
Stage1-vs-Stage4
9.917600E-01
Stage2-vs-Stage3
9.179200E-01
Stage2-vs-Stage4
8.489000E-01
Stage3-vs-Stage4
9.607600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.784800E-01
Normal-vs-AfricanAmerican
4.125800E-01
Normal-vs-Asian
3.705800E-01
Caucasian-vs-AfricanAmerican
9.451400E-01
Caucasian-vs-Asian
8.533600E-01
AfricanAmerican-vs-Asian
9.615400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.749600E-01
Normal-vs-Female
2.977000E-01
Male-vs-Female
7.446400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.179800E-01
Normal-vs-Age(41-60Yrs)
2.929000E-01
Normal-vs-Age(61-80Yrs)
2.503200E-01
Normal-vs-Age(81-100Yrs)
3.534800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.576600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.036600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.863600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.954000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.838600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.949800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.454400E-01
Normal-vs-Daily Drinker
3.795800E-01
Normal-vs-Weekly Drinker
2.905200E-01
Normal-vs-Occasional Drinker
2.732200E-01
Normal-vs-Social Drinker
2.709400E-01
Non Drinker-vs-Daily Drinker
9.736200E-01
Non Drinker-vs-Weekly Drinker
7.369200E-01
Non Drinker-vs-Occasional Drinker
8.007400E-01
Non Drinker-vs-Social Drinker
9.853800E-01
Daily Drinker-vs-Weekly Drinker
7.354400E-01
Daily Drinker-vs-Occasional Drinker
7.923800E-01
Daily Drinker-vs-Social Drinker
9.626400E-01
Weekly Drinker-vs-Occasional Drinker
9.175200E-01
Weekly Drinker-vs-Social Drinker
7.582600E-01
Occasional Drinker-vs-Social Drinker
8.240200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.207800E-01
Normal-vs-Grade 2
9.347200E-01
Normal-vs-Grade 3
8.961000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.632200E-02
Grade 1-vs-Grade 3
2.667800E-02
Grade 1-vs-Grade 4
6.207800E-01
Grade 2-vs-Grade 3
3.850000E-01
Grade 2-vs-Grade 4
9.347200E-01
Grade 3-vs-Grade 4
8.961000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.449800E-01
Normal-vs-NonDiabetic
2.933600E-01
Diabetic-vs-NonDiabetic
6.414600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.489980E-01
Normal-vs-NoPancreatitis
3.205400E-01
Pancreatitis-vs-NoPancreatitis
5.107800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.702600E-01
Normal-vs-N1
2.206200E-01
N0-vs-N1
7.528400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.590200E-02
Normal-vs-TP53-NonMutant
3.659000E-01
TP53-Mutant-vs-TP53-NonMutant
1.859570E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
